Cargando…
Sodium-glucose co-transporter-2 inhibitors: A cardiovascular outcome trial analysis
Cardiovascular outcome trials (CVOTs) have to be done by sponsors who wish to launch new antidiabetic drugs in the US, since the December 2008 US Food and Drug Administration ruling, which was subsequently accepted by the European Medicines (Evaluation) Agency (EMA) in 2012. However, the medical com...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011522/ https://www.ncbi.nlm.nih.gov/pubmed/33816202 http://dx.doi.org/10.4103/picr.PICR_156_19 |